NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Bay City Capital

Bay City Capital

San Rafael, Californiabaycitycapital.com

Overview

Bay City Capital is a life sciences investment firm with a global diversified strategy ranging from seed stage to public companies, and including innovation, restructuring opportunities, and growth investing . The firm seeks to invest in the life sciences industry, with a focus on investing in companies within the bio-pharmaceuticals, drug discovery, medical devices, nutrition, healthcare IT, and medical diagnostics sectors .

Year Founded

1997

Portfolio Companies

7

Investments

Bay City Capital investments
CompanyDateStageLead
NexCure, Inc.Nov 2018Series BCo-investor
KBP BiosciencesJan 2018Series ACo-investor
Vivaldi Biosciences, Inc.Jan 2009Series ALead
Vivaldi Biosciences, Inc.May 2007DebtCo-investor
Itamar MedicalOct 2005Series CCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersSan Rafael, California
Year Founded1997

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.